TDI-6118
TDI-6118 (Compound 5) is a potent inhibitor of EZH2. EZH2-IN-12 has the potential for the research of central nervous system malignancies[1].
Product Specifications
UNSPSC
12352005
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tdi-6118.html
Purity
99.08
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CC1=CC(C)=C(C(N1C)=O)CN2CCC3=C(C=C(C(Cl)=C3C2=O)C4=C(ON=C4C)C)Cl
Molecular Formula
C23H23Cl2N3O3
Molecular Weight
460.35
References & Citations
[1]Liang R, et al. A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors. ACS Med Chem Lett. 2022;13 (3) :377-387.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EZH2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P010-RPE-125 1x 125 µL
CD19 Mouse Monoclonal Antibody (SJ25C1), R-PE Conjugate - Biotium Choice
Sign In for Pricing
View Details 
BNC473201-100 1x 100 µL
CD137 / 4-1BB / TNFRSF9 (4-1BB/3201), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-B558920-50MG 50 mg
1,1-Bis-(4-Bromophenyl)-2,2-dichloroethylene
Sign In for Pricing
View Details 